A Senolytic Intervention Strategy is a therapeutic approach specifically designed to selectively induce apoptosis, or programmed cell death, in senescent cells—cells that have ceased dividing but remain metabolically active and secrete pro-inflammatory factors. The clinical goal is to reduce the burden of these dysfunctional cells within tissues, thereby mitigating chronic inflammation and tissue degradation associated with aging and promoting regenerative capacity. This is a key focus in advanced longevity medicine protocols.
Origin
The term is derived from ‘seno’ (old or aging) and ‘lytic’ (to destroy or dissolve), defining the targeted action of the intervention. ‘Strategy’ refers to the planned, systematic application of senolytic agents, a concept that emerged from molecular gerontology research into the mechanisms of cellular aging and senescence.
Mechanism
The mechanism involves the use of compounds, known as senolytics, that target specific pro-survival pathways within senescent cells, such as the BCL-2 family proteins, which they rely on to resist natural apoptosis. By inhibiting these pathways, the senescent cells become vulnerable and undergo self-destruction, allowing for subsequent clearance by immune cells and potentially paving the way for healthier cell replacement.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.